BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18362273)

  • 1. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Polman CH; Reingold SC; Barkhof F; Calabresi PA; Clanet M; Cohen JA; Cutter GR; Freedman MS; Kappos L; Lublin FD; McFarland HF; Metz LM; Miller AE; Montalban X; O'Connor PW; Panitch H; Richert JR; Petkau J; Schwid SR; Sormani MP; Thompson AJ; Weinshenker BG; Wolinsky JS
    Neurology; 2008 Mar; 70(13 Pt 2):1134-40. PubMed ID: 18362273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS.
    Lublin FD; Reingold SC
    Ann Neurol; 2001 May; 49(5):677-81. PubMed ID: 11357961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a placebo-controlled surgical trial an oxymoron?
    Boyle K; Batzer FR
    J Minim Invasive Gynecol; 2007; 14(3):278-83. PubMed ID: 17478356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Placebo-controlled trials in schizophrenia].
    Melamed Y; Davidson M; Bleich A
    Harefuah; 2004 Mar; 143(3):236-40, 244. PubMed ID: 15065367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
    Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C
    J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues in HIV vaccine trials in South Africa.
    Slack C; Lindegger G; Vardas E; Richter L; Strode A; Wassenaar D
    S Afr J Sci; 2000 Jun; 96():291-5. PubMed ID: 11863014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Tenser RB; Polman CH
    Neurology; 2009 Mar; 72(13):1191-2; author reply 1192. PubMed ID: 19332703
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of placebo-controlled trials: the case of asthma.
    Onder RF
    J Allergy Clin Immunol; 2005 Jun; 115(6):1228-34. PubMed ID: 15940139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo in clinical drug trials--a multidisciplinary review.
    Haegerstam G; Huitfeldt B; Nilsson BS; Sjövall J; Syvälahti E; Wahlén A
    Methods Find Exp Clin Pharmacol; 1982; 4(4):261-78. PubMed ID: 6750286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of placebo assignment in clinical trials of Parkinson's disease.
    Goetz CG; Janko K; Blasucci L; Jaglin JA
    Mov Disord; 2003 Oct; 18(10):1146-9. PubMed ID: 14534918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebos in clinical trials of peptic ulcer. ACG Committee on FDA-Related Matters.
    Smith JL
    Am J Gastroenterol; 1989 May; 84(5):469-74. PubMed ID: 2719003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ethical problems in the clinical evaluation of drugs--role of ethics committees].
    Hitzenberger G
    Wien Med Wochenschr; 2002; 152(13-14):320-2. PubMed ID: 12168513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What can be learned from open direct comparative trials in multiple sclerosis?
    Khan O
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S25-8. PubMed ID: 19200861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical framework for the use of sham procedures in clinical trials.
    Horng S; Miller FG
    Crit Care Med; 2003 Mar; 31(3 Suppl):S126-30. PubMed ID: 12626957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The legitimacy of placebo treatments in clinical practice: evidence and ethics.
    Miller FG; Colloca L
    Am J Bioeth; 2009 Dec; 9(12):39-47. PubMed ID: 20013499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethical problems of the clinical placebo use].
    Engelhardt K
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1939-42. PubMed ID: 15372375
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it ethical to use placebos in osteoporosis trials?
    Ragi-Eis S; Zerbini CA; Provenza JR; Griz LH; de Gregório LH; Russo LA; Silva NA; Borges JL; de Souza AC; Castro ML; Lewiecki EM
    J Clin Densitom; 2006; 9(3):274-80. PubMed ID: 16931344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.